Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.

Abstract
THE BENEFICIAL effects of estrogen use in postmenopausal women for management of estrogen deficiency symptoms and prevention of bone loss have been widely documented.1,2 The addition of a progestin, especially in a continuous manner, has been shown to reduce the risk of endometrial cancer associated with unopposed estrogen use in women with an intact uterus.3-5